Strategic Partners A/S

F:1TB0 Germany Biotechnology
Market Cap
$3.23 Million
€3.14 Million EUR
Market Cap Rank
#35426 Global
#4182 in Germany
Share Price
€76.00
Change (1 day)
+0.00%
52-Week Range
€74.60 - €96.00
All Time High
€96.00
About

Strategic Partners A/S does not have significant operations. Previously, it was engaged in biotech activities. The company was formerly known as Orphazyme A/S and changed its name to Strategic Partners A/S in October 2024. The company was founded in 2009 and is based in Herlev, Denmark.

Strategic Partners A/S (1TB0) - Total Liabilities

Latest total liabilities as of June 2025: €789.00K EUR

Based on the latest financial reports, Strategic Partners A/S (1TB0) has total liabilities worth €789.00K EUR as of June 2025.

Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Strategic Partners A/S - Total Liabilities Trend (2021–2024)

This chart illustrates how Strategic Partners A/S's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.

Strategic Partners A/S Competitors by Total Liabilities

The table below lists competitors of Strategic Partners A/S ranked by their total liabilities.

Company Country Total Liabilities
Dantax
CO:DANT
Denmark Dkr11.13 Million
Dogwood Therapeutics, Inc.
NASDAQ:DWTX
USA $14.61 Million
Lexston Life Sciences Corp
OTCQB:LEXTF
USA $139.01K
AS Ekspress Grupp
F:DYC
Germany €56.51 Million

Liability Composition Analysis (2021–2024)

This chart breaks down Strategic Partners A/S's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 19.36 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.04 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.04 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Strategic Partners A/S's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Strategic Partners A/S (2021–2024)

The table below shows the annual total liabilities of Strategic Partners A/S from 2021 to 2024.

Year Total Liabilities Change
2024-12-31 €4.31 Million -14.99%
2023-12-31 €5.07 Million -96.91%
2021-12-31 €163.89 Million --